The associations between blood zinc levels and cancer risk in BRCA1 mutation carriers, which we described in an earlier publication [27], did not show a statistically significant reduction in the risk of any of the cancers; we observed tendencies, although not statistically significant, for ovarian and breast cancers. This evidence concerns the gene BRCA1 and breast cancer.